Ji Hwan Bang
- Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions 27
- HIV/AIDS drug development and treatment 16
- SARS-CoV-2 and COVID-19 Research 15
- COVID-19 Clinical Research Studies 12
- Antimicrobial Resistance in Staphylococcus 12
- Modeling and Simulation top 1%
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing 17
- Virology top 5%
- HIV Research and Treatment 12
-
- HIV, Drug Use, Sexual Risk 12
Ji Hwan Bang
123 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 133
- Infectious Diseases 1.8k
- Applied Microbiology and Biotechnology 133
- Modeling and Simulation 209
- Clinical Biochemistry 224
- Virology 114
Countries citing papers authored by Ji Hwan Bang
This map shows the geographic impact of Ji Hwan Bang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Hwan Bang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Hwan Bang more than expected).
Fields of papers citing papers by Ji Hwan Bang
This network shows the impact of papers produced by Ji Hwan Bang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Hwan Bang. The network helps show where Ji Hwan Bang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ji Hwan Bang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 3 | |
| 8 | 2020 | 0 | |
| 9 | 2020 | 2 | |
| 10 | 2019 | 9 | |
| 11 | 2019 | 6 | |
| 12 | 2019 | 3 | |
| 13 | 2018 | 70 | |
| 14 | 2018 | 14 | |
| 15 | 2018 | 1 | |
| 16 | 2018 | 6 | |
| 17 | 2016 | 4 | |
| 18 | 2016 | 156 | |
| 19 | 2016 | 12 | |
| 20 | Epidemiology and Prevention Strategies of Rabies in Korea | 2005 | 2 |
About Ji Hwan Bang
Ji Hwan Bang is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Virology, having authored 128 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (27 papers), Bacterial Identification and Susceptibility Testing (17 papers), HIV/AIDS drug development and treatment (16 papers), SARS-CoV-2 and COVID-19 Research (15 papers), HIV Research and Treatment (12 papers), HIV, Drug Use, Sexual Risk (12 papers), COVID-19 Clinical Research Studies (12 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Applied Microbiology and Biotechnology (133 citations) and Modeling and Simulation (209 citations). Ji Hwan Bang has collaborated with scholars based in South Korea, Ethiopia and United States. Frequent co-authors include Myoung‐don Oh, Hong Bin Kim, Nam Joong Kim, Sang‐Won Park, Pyoeng Gyun Choe, Eu Suk Kim, Kyoung‐Ho Song, Wan Beom Park, Chang Kyung Kang and Eunyoung Lee. Their work appears in journals such as PLoS ONE, The Science of The Total Environment and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.